Search

everythinglearnresearchcommunity

for

Search:↓

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

SLE and DM can coexist but are rare and need careful evaluation.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Hydroxychloroquine may help delay skin damage in lupus patients.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Hydroxychloroquine may help COVID-19 patients with lupus.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.